Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China.

Alimentary pharmacology & therapeutics - 1 Dec 2016

Qi X, Han G, Guo X, De Stefano V, Xu K, Lu Z, Xu H, Mancuso A, Zhang W, Han X, Valla D C, Fan D

Abstract excerpt

BACKGROUND: China may have the largest number of Budd-Chiari syndrome (BCS) cases in the world (at least 1914 original papers were published, and at least 20 191 BCS patients were reported). Considering the discrepancy in the clinical profiles and preferred treatment selection of primary BCS between the West and China, understanding its aetiology in these two different regions is very important. AIM: To review...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Antiphospholipid
Share to Budd-Chiari Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor V

Share to Hematologic Diseases

Share to Hyperhomocysteinemia

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Poverty

Share to Prothrombin

Source

Identifiers

PMID: 27734511
DOI: 10.1111/apt.13815

Genes

MTHFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China.PMID 27734511Read ↗

Thrombotic risk factors in Chinese Budd-Chiari syndrome patients. An observational study with a systematic review of the literature.Semantic proximity Read ↗

Association of factor V Leiden, Janus kinase 2, prothrombin, and MTHFR mutations with primary Budd-Chiari syndrome in Egyptian patients.Semantic proximity Read ↗

Epidemiological aspects of Budd-Chiari in Egyptian patients: a single-center study.Semantic proximity Read ↗

Prevalence of prothrombotic factors in patients with Budd-Chiari syndrome or non-cirrhotic nonmalignant portal vein thrombosis: A hospital-based observational study.Semantic proximity Read ↗

Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis.Semantic proximity Read ↗

Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: a study from North India.Semantic proximity Read ↗

Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study.Semantic proximity Read ↗

The relationship between the levels and function of endothelial progenitor cells and factor V Leiden and protein C deficiency in patients with primary Budd-Chiari syndrome.Semantic proximity Read ↗

Prothrombotic states in portal vein thrombosis and Budd-Chiari syndrome in India: A systematic review and meta-analysis.Semantic proximity Read ↗

Hyperhomocysteinaemia and factor V Leiden mutation are associated with Budd-Chiari syndrome.Semantic proximity Read ↗

Risk of Budd-Chiari syndrome associated with factor V Leiden and G20210A prothrombin mutation: a meta-analysis.Semantic proximity Read ↗

Budd-Chiari syndrome has different presentations and disease severity during adolescence.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.